[OP.6C.01] NEW EPIDEMIOLOGIC NATIONAL REPRESENTATIVE SURVEY: SEPHAR III - MAIN RESULTS. (September 2017)

• Record Type: Journal Article
• Authors: Dorobantu, M.; Darabont, R.; Dimulescu, D.; Sinescu, C.; Arsenescu-georgescu, C.; Lighezan, D.; Gusbeth-tatomir, P.; Babes, K.; Brinza, I.; Udrescu, M.; Tautu, O.
• Is Part Of: Journal of hypertension. Volume 35(2017)Supplement 2
• Publication Date: 2017-09
• Subjects: Hypertension -- Periodicals; Hypertension -- Periodicals; 616.132005
• DOI: 10.1097/01.hjh.0000523132.85277.15
• Languages: English
• ISSNs: 1473-5598

Abstract

Abstract : Objective: To estimate the trend in HT prevalence, treatment, and control in Romania, that has a crucial importance for the development of prevention strategies at national level, urgently needed in a very high CV risk SE European country. Design and method: A representative sample of 1970 Romanian adults (mean age 48.38 years, age range 18–80 years, 52.5%females, 70% response rate), were enrolled after signing written informed consent. The 2 study visits (Figure 1) took part in a special 'medical caravan' entitled SEPHAR BUS. Figure. No caption available. HT was defined as study SBP >/= 140 mmHg and/or study DBP >/= 90 mmHg at both study visits or previously diagnosed HT treated in the last two weeks, regardless of BP values. BP control was defined as SBP < 140 mmHg and DBP < 90 mmHg in hypertensive subjects. Results: General HT prevalence is 45.1% (8.6% newly diagnosed HT, 53.8% awareness of HT), increasing with age (18–24 years – 15, 4% vs. 25–34 years – 21.6% vs. 35–44 years – 34.6% vs. 45–54 years – 50.3% vs. 65–74 years – 62.6% vs. 65–74 years – 70% vs. >75years – 62.4%) regardless of the gender and area of residence. While majority (72.2%) of hypertensive subjects were treated (51.9% with >/= 2 drugs) only 30.8% of them had controlled BP values (general control rate 22.3%). Following the evolution from the last 10 years, it is expected that in 2020 the prevalence of HT will increase up to 44%, the awareness up to 96.2%, treatment of HT up to 91.2% and BP treatment control up to 36.6%. Conclusions: Hypertension prevalence in Romania is increasing, although together with an increase in awareness, treatment and control. Possible explanations of this trend might be: unhealthy life-style and diet, increased salt-intake and increase in obesity and diabetes mellitus. SEPHAR III survey represent a necessary step in HT management in our country offering an estimation of a real trend in HT prevalence, treatment, and control, trend that will serve as base for future prevention strategies, which are urgently needed in a very high CV risk SE European country.